 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 06, 2012
Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- As Rivals Vie for Share of Noninvasive Trisomy Testing Market, Physicians See Value for Screening
July 3, 2012 / Clinical Sequencing News - Sequenom Plans Sample-Prep Automation, Increased Multiplexing to Double MaterniT21 Capacity
May 9, 2012 / Clinical Sequencing News - Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011 / Clinical Sequencing News - Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News - Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 1, 2012 / Clinical Sequencing News